Erdman, V.V.,
Karimov, D.D.,
Tuktarova, I.A.,
Petintseva, A.A.,
Timasheva, Y.R.,
Nasibullin, T.R. (2025) ). The survival amid the persons with various clinical phenotypes was associated with the Alu
polymorphismEnikeeva, R,
Kazantseva, A,
Takhirova, Z,
Lobaskova, M,
Davydova, Y,
Mustafin, R,
Malykh, S,
Khusnutdinova, E (2021) Familial environment modifies association of DNA methyltransferases gene
variants and cognitive
THE ROLE OF THE IL2-IL21 RS6822844
POLYMORPHISM IN THE PREDISPOSITION TO THE ERYTHROCYTE
Erdman, V.V.,
Nasibullin, T.R.,
Tuktarova, I.A.,
Timasheva, Y.R.,
Danilko, K.V.,
Viktorova, T.V.,
Mustafina, O.E. (2020) the
polymorphic markers in the genes of the antioxidant defense enzymes—SOD1 (rs2070424), SOD2 (rs4880), and SOD3
nucleotide
polymorphisms (SNPs) (rs13180, rs16969968, rs1051730, rs6495309, rs7671167, rs13118928) were
The involvement of
polymorphisms of genes encoding immune response-associated molecules (LTA, TNFA
of
polymorphic markers in six chemokine
genes (CXCL13, CCL8, CCL16, CCL17, CCL18, and CCL23) was performed
Elena, Merkuryeva,
Tatiana, Markova,
Anton, Tyurin,
Diana, Valeeva,
Vladimir, Kenis,
Maria, Sumina,
Igor, Sorokin,
Olga, Shchagina,
Mikhail, Skoblov,
Maria, Nefedova,
Rita, Khusainova,
Ekaterina, Zakharova,
Dadali, Elena,
Kutsev, Sergey (2023) with osteogenesis imperfecta. The disease is caused by pathogenic
variants in the
SGMS2 gene, the protein product
of the study was to assess whether the PADI4 rs2240336
gene
polymorphism is a predictor of the disease severity